Johnson Pharmacare Ltd

On 13-Feb, Johnson Pharmacare Ltd’s stock price declined by 1.67%, closing at ₹0.59, reflecting a modest pullback after recent gains despite a generally positive monthly and year-to-date performance relative to the Sensex.

The next results date for Johnson Pharmacare Ltd is 14 February 2026.

The next results date for Johnson Pharmacare Ltd is 12 February 2026.

Johnson Pharma has experienced significant declines in revenue and profitability, with net sales dropping from 3.26 Cr in March 2022 to 0.00 Cr by March 2025, resulting in increasing operating and net losses. Total assets and liabilities decreased, and cash flow turned negative, indicating a downward trend in financial stability.

The next results date for Johnson Pharma is 14 November 2025.

As of 15-Oct, Johnson Pharmacare Ltd's stock price is Rs. 0.63, down 1.56%, and has reached a 52-week low of Rs. 0.60. The stock has underperformed significantly against the benchmark, with a year-to-date decline of 44.74% compared to the Sensex's gain of 5.72%.

As of 09-Oct, Johnson Pharmacare Ltd's stock price is at 0.69, down 5.48% and recently hitting a 52-week low of Rs. 0.66. The stock has underperformed significantly compared to the Sensex, with a year-to-date decline of 39.47%, despite a recent increase in investor participation.

As of 08-Oct, Johnson Pharmacare Ltd's stock price is Rs. 0.74, down 1.33%, and has reached a 52-week low of Rs. 0.72. The stock is underperforming significantly compared to the market, with a year-to-date decline of 35.09%, indicating a bearish trend and reduced investor confidence.

As of 24-Sep, Johnson Pharmacare Ltd's stock price is Rs. 0.77, having increased by 1.32% after a decline, but it has reached a new 52-week low and is trading below all key moving averages, indicating a bearish trend. Despite a slight uptick, the stock's overall performance remains weak, with a year-to-date decline of 32.46% and underperformance compared to the market.

As of 23-Sep, Johnson Pharmacare Ltd's stock price is Rs 0.76, down 1.3%, and has fallen 3.8% over the past month, trading below key moving averages and near its 52-week low. Despite increased investor participation, the stock's year-to-date decline of 33.33% starkly contrasts with the Sensex's 5.07% gain, indicating significant underperformance.

As of 22-Sep, Johnson Pharmacare Ltd is facing a decline in stock price, currently at Rs 0.77, down 1.28%, and has underperformed its sector and the benchmark Sensex significantly. The stock is on a bearish trend, trading below moving averages, close to its 52-week low, and experiencing reduced investor interest.

As of 19-Sep, Johnson Pharmacare Ltd's stock price is Rs 0.78, down 1.27% and near its 52-week low. The stock has significantly underperformed the Sensex year-to-date, declining 31.58% compared to the index's 5.74% gain.

As of 18-Sep, Johnson Pharmacare Ltd's stock price is at 0.79, showing a slight increase but underperforming compared to the broader market and experiencing significant declines year-to-date. Despite a recent uptick, long-term challenges persist, as the stock remains below key moving averages.

As of 17-Sep, Johnson Pharmacare Ltd is priced at 0.78, showing no change and underperforming the sector. The stock is in a bearish trend, trading below key moving averages and close to its 52-week low, with a significant year-to-date decline of -31.58%.

As of 16-Sep, Johnson Pharmacare Ltd is priced at 0.78 with no change, underperforming its sector and trading below all moving averages, indicating a bearish trend. The stock has declined 31.58% year-to-date and is close to its 52-week low, reflecting significant challenges in the broader market.

As of 15-Sep, Johnson Pharmacare Ltd is priced at 0.78, showing a slight increase but still trading below all key moving averages. Despite a recent uptick and increased investor interest, the stock has significantly underperformed year-to-date and over the past year compared to the benchmark Sensex.